| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 490 | 357 | 20 |
| Full Text Views | 2 | 2 | 0 |
| PDF Downloads | 3 | 3 | 0 |
Fluorescent Antibody Studies in Human Malaria
I. Development of Antibodies to Plasmodium Malariae
William E. Collins
William E. Collins
Department of Health, Education, and Welfare, Public Health Service, National Institute of Allergy and Infectious Diseases, Laboratory of Parasite Chemotherapy, Section on Cytology, P. O. Box 195, Chamblee, Georgia
Search for other papers by William E. Collins in
Current site
Google Scholar
PubMed
Search for other papers by William E. Collins in
Current site
Google Scholar
PubMed
Geoffrey M. Jeffery
Geoffrey M. Jeffery
Department of Health, Education, and Welfare, Public Health Service, National Institute of Allergy and Infectious Diseases, Laboratory of Parasite Chemotherapy, Section on Cytology, P. O. Box 195, Chamblee, Georgia
Search for other papers by Geoffrey M. Jeffery in
Current site
Google Scholar
PubMed
Search for other papers by Geoffrey M. Jeffery in
Current site
Google Scholar
PubMed
Jimmie C. Skinner
Jimmie C. Skinner
Department of Health, Education, and Welfare, Public Health Service, National Institute of Allergy and Infectious Diseases, Laboratory of Parasite Chemotherapy, Section on Cytology, P. O. Box 195, Chamblee, Georgia
Search for other papers by Jimmie C. Skinner in
Current site
Google Scholar
PubMed
Search for other papers by Jimmie C. Skinner in
Current site
Google Scholar
PubMed
Summary
Using the indirect fluorescent antibody method, the production and persistence of specific antibody was demonstrated in three patients inoculated with blood parasites of Plasmodium malariae. In one case a relatively high antibody level was maintained in association with persistent asymptomatic parasitemia, while in one of the others, termination of the infection resulted in a delayed, slow decline in antibody titer to a persistent lower level. Higher antibody titer appeared to be associated with the primary infection characterized by reduced parasitemia and febrile attack.
Author Notes
Present address: Laboratory of Parasite Chemotherapy, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda 14, Maryland.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 490 | 357 | 20 |
| Full Text Views | 2 | 2 | 0 |
| PDF Downloads | 3 | 3 | 0 |